Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03624036
Title Safety and Efficacy of KTE-C19 in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia (ZUMA-8)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Kite, A Gilead Company

chronic lymphocytic leukemia


Cyclophosphamide + Fludarabine

axicabtagene ciloleucel

Age Groups: adult | senior
Covered Countries USA | ITA

No variant requirements are available.